APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galidesivir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Galidesivir Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchGalidesivir Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Galidesivir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Galidesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galidesivir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Galidesivir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Galidesivir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Galidesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Galidesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Galidesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Galidesivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Galidesivir include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Galidesivir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Galidesivir, also provides the sales of main regions and countries. Of the upcoming market potential for Galidesivir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Galidesivir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Galidesivir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Galidesivir sales, projected growth trends, production technology, application and end-user industry.

Galidesivir Segment by Company

BioCryst Pharmaceuticals

Cayman Chemical

ChemScene

CliniSciences

Taiclone

Xi'an Henrikang Biotech Co.

Galidesivir Segment by Type

Galidesivir Powder

Galidesivir Hydrochloride

Galidesivir Segment by Application

Yellow Fever

Marburg Virus Disease

Filovirus Infections/Ebola Virus Infection

Galidesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Galidesivir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Galidesivir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Galidesivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Galidesivir Powder Major Manufacturers Table 3. Galidesivir Hydrochloride Major Manufacturers Table 4. Global Galidesivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Yellow Fever Major Manufacturers Table 6. Marburg Virus Disease Major Manufacturers Table 7. Filovirus Infections/Ebola Virus Infection Major Manufacturers Table 8. Galidesivir Industry Trends Table 9. Galidesivir Industry Drivers Table 10. Galidesivir Industry Opportunities and Challenges Table 11. Galidesivir Industry Restraints Table 12. Global Galidesivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Galidesivir Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Galidesivir Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Galidesivir Revenue Market Share by Region (2021-2026) Table 16. Global Galidesivir Revenue Market Share by Region (2027-2032) Table 17. Global Galidesivir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Galidesivir Sales by Region (2021-2026) & (Tons) Table 19. Global Galidesivir Sales by Region (2027-2032) & (Tons) Table 20. Global Galidesivir Sales Market Share by Region (2021-2026) Table 21. Global Galidesivir Sales Market Share by Region (2027-2032) Table 22. Global Galidesivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Galidesivir Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Galidesivir Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Galidesivir Sales Market Share by Manufacturers (2021-2026) Table 26. Global Galidesivir Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Galidesivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Galidesivir Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Galidesivir Manufacturers, Product Type & Application Table 30. Global Galidesivir Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Galidesivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Galidesivir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Galidesivir Revenue Market Share by Type (2021-2026) Table 37. Global Galidesivir Revenue Market Share by Type (2027-2032) Table 38. Global Galidesivir Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Galidesivir Sales by Type (2021-2026) & (Tons) Table 40. Global Galidesivir Sales by Type (2027-2032) & (Tons) Table 41. Global Galidesivir Sales Market Share by Type (2021-2026) Table 42. Global Galidesivir Sales Market Share by Type (2027-2032) Table 43. Global Galidesivir Price by Type (2021-2026) & (US$/Kg) Table 44. Global Galidesivir Price by Type (2027-2032) & (US$/Kg) Table 45. Global Galidesivir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Galidesivir Revenue Market Share by Application (2021-2026) Table 49. Global Galidesivir Revenue Market Share by Application (2027-2032) Table 50. Global Galidesivir Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Galidesivir Sales by Application (2021-2026) & (Tons) Table 52. Global Galidesivir Sales by Application (2027-2032) & (Tons) Table 53. Global Galidesivir Sales Market Share by Application (2021-2026) Table 54. Global Galidesivir Sales Market Share by Application (2027-2032) Table 55. Global Galidesivir Price by Application (2021-2026) & (US$/Kg) Table 56. Global Galidesivir Price by Application (2027-2032) & (US$/Kg) Table 57. BioCryst Pharmaceuticals Company Information Table 58. BioCryst Pharmaceuticals Business Overview Table 59. BioCryst Pharmaceuticals Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. BioCryst Pharmaceuticals Galidesivir Product Portfolio Table 61. BioCryst Pharmaceuticals Recent Development Table 62. Cayman Chemical Company Information Table 63. Cayman Chemical Business Overview Table 64. Cayman Chemical Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Cayman Chemical Galidesivir Product Portfolio Table 66. Cayman Chemical Recent Development Table 67. ChemScene Company Information Table 68. ChemScene Business Overview Table 69. ChemScene Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. ChemScene Galidesivir Product Portfolio Table 71. ChemScene Recent Development Table 72. CliniSciences Company Information Table 73. CliniSciences Business Overview Table 74. CliniSciences Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. CliniSciences Galidesivir Product Portfolio Table 76. CliniSciences Recent Development Table 77. Taiclone Company Information Table 78. Taiclone Business Overview Table 79. Taiclone Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Taiclone Galidesivir Product Portfolio Table 81. Taiclone Recent Development Table 82. Xi'an Henrikang Biotech Co. Company Information Table 83. Xi'an Henrikang Biotech Co. Business Overview Table 84. Xi'an Henrikang Biotech Co. Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio Table 86. Xi'an Henrikang Biotech Co. Recent Development Table 87. North America Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Galidesivir Sales by Type (2021-2026) & (Tons) Table 90. North America Galidesivir Sales by Type (2027-2032) & (Tons) Table 91. North America Galidesivir Sales Price by Type (2021-2026) & (US$/Kg) Table 92. North America Galidesivir Sales Price by Type (2027-2032) & (US$/Kg) Table 93. North America Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Galidesivir Sales by Application (2021-2026) & (Tons) Table 96. North America Galidesivir Sales by Application (2027-2032) & (Tons) Table 97. North America Galidesivir Sales Price by Application (2021-2026) & (US$/Kg) Table 98. North America Galidesivir Sales Price by Application (2027-2032) & (US$/Kg) Table 99. North America Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Galidesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Galidesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Galidesivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 103. North America Galidesivir Sales by Country (2021-2026) & (Tons) Table 104. North America Galidesivir Sales by Country (2027-2032) & (Tons) Table 105. North America Galidesivir Sales Price by Country (2021-2026) & (US$/Kg) Table 106. North America Galidesivir Sales Price by Country (2027-2032) & (US$/Kg) Table 107. United States Galidesivir Revenue (2021-2032) & (US$ Million) Table 108. Canada Galidesivir Revenue (2021-2032) & (US$ Million) Table 109. Europe Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Galidesivir Sales by Type (2021-2026) & (Tons) Table 112. Europe Galidesivir Sales by Type (2027-2032) & (Tons) Table 113. Europe Galidesivir Sales Price by Type (2021-2026) & (US$/Kg) Table 114. Europe Galidesivir Sales Price by Type (2027-2032) & (US$/Kg) Table 115. Europe Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Galidesivir Sales by Application (2021-2026) & (Tons) Table 118. Europe Galidesivir Sales by Application (2027-2032) & (Tons) Table 119. Europe Galidesivir Sales Price by Application (2021-2026) & (US$/Kg) Table 120. Europe Galidesivir Sales Price by Application (2027-2032) & (US$/Kg) Table 121. Europe Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Galidesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Galidesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Galidesivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 125. Europe Galidesivir Sales by Country (2021-2026) & (Tons) Table 126. Europe Galidesivir Sales by Country (2027-2032) & (Tons) Table 127. Europe Galidesivir Sales Price by Country (2021-2026) & (US$/Kg) Table 128. Europe Galidesivir Sales Price by Country (2027-2032) & (US$/Kg) Table 129. Germany Galidesivir Revenue (2021-2032) & (US$ Million) Table 130. France Galidesivir Revenue (2021-2032) & (US$ Million) Table 131. U.K. Galidesivir Revenue (2021-2032) & (US$ Million) Table 132. Italy Galidesivir Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Galidesivir Revenue (2021-2032) & (US$ Million) Table 134. China Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 135. China Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 136. China Galidesivir Sales by Type (2021-2026) & (Tons) Table 137. China Galidesivir Sales by Type (2027-2032) & (Tons) Table 138. China Galidesivir Sales Price by Type (2021-2026) & (US$/Kg) Table 139. China Galidesivir Sales Price by Type (2027-2032) & (US$/Kg) Table 140. China Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 141. China Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 142. China Galidesivir Sales by Application (2021-2026) & (Tons) Table 143. China Galidesivir Sales by Application (2027-2032) & (Tons) Table 144. China Galidesivir Sales Price by Application (2021-2026) & (US$/Kg) Table 145. China Galidesivir Sales Price by Application (2027-2032) & (US$/Kg) Table 146. Asia Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Galidesivir Sales by Type (2021-2026) & (Tons) Table 149. Asia Galidesivir Sales by Type (2027-2032) & (Tons) Table 150. Asia Galidesivir Sales Price by Type (2021-2026) & (US$/Kg) Table 151. Asia Galidesivir Sales Price by Type (2027-2032) & (US$/Kg) Table 152. Asia Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Galidesivir Sales by Application (2021-2026) & (Tons) Table 155. Asia Galidesivir Sales by Application (2027-2032) & (Tons) Table 156. Asia Galidesivir Sales Price by Application (2021-2026) & (US$/Kg) Table 157. Asia Galidesivir Sales Price by Application (2027-2032) & (US$/Kg) Table 158. Asia Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Galidesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Galidesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Galidesivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 162. Asia Galidesivir Sales by Country (2021-2026) & (Tons) Table 163. Asia Galidesivir Sales by Country (2027-2032) & (Tons) Table 164. Asia Galidesivir Sales Price by Country (2021-2026) & (US$/Kg) Table 165. Asia Galidesivir Sales Price by Country (2027-2032) & (US$/Kg) Table 166. Japan Galidesivir Revenue (2021-2032) & (US$ Million) Table 167. South Korea Galidesivir Revenue (2021-2032) & (US$ Million) Table 168. India Galidesivir Revenue (2021-2032) & (US$ Million) Table 169. Australia Galidesivir Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Galidesivir Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Galidesivir Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Galidesivir Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Galidesivir Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Galidesivir Sales by Type (2021-2026) & (Tons) Table 175. SAMEA Galidesivir Sales by Type (2027-2032) & (Tons) Table 176. SAMEA Galidesivir Sales Price by Type (2021-2026) & (US$/Kg) Table 177. SAMEA Galidesivir Sales Price by Type (2027-2032) & (US$/Kg) Table 178. SAMEA Galidesivir Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Galidesivir Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Galidesivir Sales by Application (2021-2026) & (Tons) Table 181. SAMEA Galidesivir Sales by Application (2027-2032) & (Tons) Table 182. SAMEA Galidesivir Sales Price by Application (2021-2026) & (US$/Kg) Table 183. SAMEA Galidesivir Sales Price by Application (2027-2032) & (US$/Kg) Table 184. SAMEA Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Galidesivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Galidesivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Galidesivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 188. SAMEA Galidesivir Sales by Country (2021-2026) & (Tons) Table 189. SAMEA Galidesivir Sales by Country (2027-2032) & (Tons) Table 190. SAMEA Galidesivir Sales Price by Country (2021-2026) & (US$/Kg) Table 191. SAMEA Galidesivir Sales Price by Country (2027-2032) & (US$/Kg) Table 192. Brazil Galidesivir Revenue (2021-2032) & (US$ Million) Table 193. Argentina Galidesivir Revenue (2021-2032) & (US$ Million) Table 194. Chile Galidesivir Revenue (2021-2032) & (US$ Million) Table 195. Colombia Galidesivir Revenue (2021-2032) & (US$ Million) Table 196. Peru Galidesivir Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Galidesivir Revenue (2021-2032) & (US$ Million) Table 198. Israel Galidesivir Revenue (2021-2032) & (US$ Million) Table 199. UAE Galidesivir Revenue (2021-2032) & (US$ Million) Table 200. Turkey Galidesivir Revenue (2021-2032) & (US$ Million) Table 201. Iran Galidesivir Revenue (2021-2032) & (US$ Million) Table 202. Egypt Galidesivir Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Galidesivir Distributors List Table 206. Galidesivir Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Galidesivir Image Figure 2. Global Galidesivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galidesivir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Galidesivir Powder Image Figure 5. Galidesivir Hydrochloride Image Figure 6. Global Galidesivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Galidesivir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Yellow Fever Image Figure 9. Marburg Virus Disease Image Figure 10. Filovirus Infections/Ebola Virus Infection Image Figure 11. Global Galidesivir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Galidesivir Revenue (2021-2032) & (US$ Million) Figure 13. Global Galidesivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Galidesivir Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Galidesivir Revenue Market Share by Region (2021-2032) Figure 16. Global Galidesivir Sales (2021-2032) & (Tons) Figure 17. Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Galidesivir Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Galidesivir Sales YoY (2021-2032) & (Tons) Figure 20. Europe Galidesivir Sales YoY (2021-2032) & (Tons) Figure 21. China Galidesivir Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Galidesivir Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Galidesivir Sales YoY (2021-2032) & (Tons) Figure 24. Global Galidesivir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Galidesivir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Galidesivir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Galidesivir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Galidesivir Revenue Market Share by Type (2021-2032) Figure 30. Global Galidesivir Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Galidesivir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Galidesivir Sales Market Share by Type (2021-2032) Figure 33. Global Galidesivir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Galidesivir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Galidesivir Revenue Market Share by Application (2021-2032) Figure 36. Global Galidesivir Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Galidesivir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Galidesivir Sales Market Share by Application (2021-2032) Figure 39. North America Galidesivir Revenue Share by Type (2021-2032) Figure 40. North America Galidesivir Sales Share by Type (2021-2032) Figure 41. North America Galidesivir Revenue Share by Application (2021-2032) Figure 42. North America Galidesivir Sales Share by Application (2021-2032) Figure 43. North America Galidesivir Revenue Share by Country (2021-2032) Figure 44. North America Galidesivir Sales Share by Country (2021-2032) Figure 45. Europe Galidesivir Revenue Share by Type (2021-2032) Figure 46. Europe Galidesivir Sales Share by Type (2021-2032) Figure 47. Europe Galidesivir Revenue Share by Application (2021-2032) Figure 48. Europe Galidesivir Sales Share by Application (2021-2032) Figure 49. Europe Galidesivir Revenue Share by Country (2021-2032) Figure 50. Europe Galidesivir Sales Share by Country (2021-2032) Figure 51. China Galidesivir Revenue Share by Type (2021-2032) Figure 52. China Galidesivir Sales Share by Type (2021-2032) Figure 53. China Galidesivir Revenue Share by Application (2021-2032) Figure 54. China Galidesivir Sales Share by Application (2021-2032) Figure 55. Asia Galidesivir Revenue Share by Type (2021-2032) Figure 56. Asia Galidesivir Sales Share by Type (2021-2032) Figure 57. Asia Galidesivir Revenue Share by Application (2021-2032) Figure 58. Asia Galidesivir Sales Share by Application (2021-2032) Figure 59. Asia Galidesivir Revenue Share by Country (2021-2032) Figure 60. Asia Galidesivir Sales Share by Country (2021-2032) Figure 61. SAMEA Galidesivir Revenue Share by Type (2021-2032) Figure 62. SAMEA Galidesivir Sales Share by Type (2021-2032) Figure 63. SAMEA Galidesivir Revenue Share by Application (2021-2032) Figure 64. SAMEA Galidesivir Sales Share by Application (2021-2032) Figure 65. SAMEA Galidesivir Revenue Share by Country (2021-2032) Figure 66. SAMEA Galidesivir Sales Share by Country (2021-2032) Figure 67. Galidesivir Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Galidesivir Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Galidesivir Powder
  • Galidesivir Hydrochloride
Applications
  • Yellow Fever
  • Marburg Virus Disease
  • Filovirus Infections/Ebola Virus Infection
Companies covered
  • BioCryst Pharmaceuticals
  • Cayman Chemical
  • ChemScene
  • CliniSciences
  • Taiclone
  • Xi'an Henrikang Biotech Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Galidesivir Market by Type
  3. 1.2.1 Global Galidesivir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Galidesivir Powder
  5. 1.2.3 Galidesivir Hydrochloride
  6. 1.3 Galidesivir Market by Application
  7. 1.3.1 Global Galidesivir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Yellow Fever
  9. 1.3.3 Marburg Virus Disease
  10. 1.3.4 Filovirus Infections/Ebola Virus Infection
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Galidesivir Market Dynamics
  1. 2.1 Galidesivir Industry Trends
  2. 2.2 Galidesivir Industry Drivers
  3. 2.3 Galidesivir Industry Opportunities and Challenges
  4. 2.4 Galidesivir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Galidesivir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Galidesivir Revenue by Region
  3. 3.2.1 Global Galidesivir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Galidesivir Revenue by Region (2021-2026)
  5. 3.2.3 Global Galidesivir Revenue by Region (2027-2032)
  6. 3.2.4 Global Galidesivir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Galidesivir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Galidesivir Sales by Region
  9. 3.4.1 Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Galidesivir Sales by Region (2021-2026)
  11. 3.4.3 Global Galidesivir Sales by Region (2027-2032)
  12. 3.4.4 Global Galidesivir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Galidesivir Revenue by Manufacturers
  2. 4.1.1 Global Galidesivir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Galidesivir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Galidesivir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Galidesivir Sales by Manufacturers
  6. 4.2.1 Global Galidesivir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Galidesivir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Galidesivir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Galidesivir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Galidesivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Galidesivir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Galidesivir Manufacturers, Product Type & Application
  13. 4.7 Global Galidesivir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Galidesivir Market CR5 and HHI
  16. 4.8.2 2025 Galidesivir Tier 1, Tier 2, and Tier 3
5 Galidesivir Market by Type
  1. 5.1 Global Galidesivir Revenue by Type
  2. 5.1.1 Global Galidesivir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Galidesivir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Galidesivir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Galidesivir Sales by Type
  6. 5.2.1 Global Galidesivir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galidesivir Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Galidesivir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Galidesivir Price by Type
6 Galidesivir Market by Application
  1. 6.1 Global Galidesivir Revenue by Application
  2. 6.1.1 Global Galidesivir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Galidesivir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Galidesivir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Galidesivir Sales by Application
  6. 6.2.1 Global Galidesivir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Galidesivir Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Galidesivir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Galidesivir Price by Application
7 Company Profiles
  1. 7.1 BioCryst Pharmaceuticals
  2. 7.1.1 BioCryst Pharmaceuticals Company Information
  3. 7.1.2 BioCryst Pharmaceuticals Business Overview
  4. 7.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
  6. 7.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 7.2 Cayman Chemical
  8. 7.2.1 Cayman Chemical Company Information
  9. 7.2.2 Cayman Chemical Business Overview
  10. 7.2.3 Cayman Chemical Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cayman Chemical Galidesivir Product Portfolio
  12. 7.2.5 Cayman Chemical Recent Developments
  13. 7.3 ChemScene
  14. 7.3.1 ChemScene Company Information
  15. 7.3.2 ChemScene Business Overview
  16. 7.3.3 ChemScene Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ChemScene Galidesivir Product Portfolio
  18. 7.3.5 ChemScene Recent Developments
  19. 7.4 CliniSciences
  20. 7.4.1 CliniSciences Company Information
  21. 7.4.2 CliniSciences Business Overview
  22. 7.4.3 CliniSciences Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CliniSciences Galidesivir Product Portfolio
  24. 7.4.5 CliniSciences Recent Developments
  25. 7.5 Taiclone
  26. 7.5.1 Taiclone Company Information
  27. 7.5.2 Taiclone Business Overview
  28. 7.5.3 Taiclone Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taiclone Galidesivir Product Portfolio
  30. 7.5.5 Taiclone Recent Developments
  31. 7.6 Xi'an Henrikang Biotech Co.
  32. 7.6.1 Xi'an Henrikang Biotech Co. Company Information
  33. 7.6.2 Xi'an Henrikang Biotech Co. Business Overview
  34. 7.6.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
  36. 7.6.5 Xi'an Henrikang Biotech Co. Recent Developments
8 North America
  1. 8.1 North America Galidesivir Market Size by Type
  2. 8.1.1 North America Galidesivir Revenue by Type (2021-2032)
  3. 8.1.2 North America Galidesivir Sales by Type (2021-2032)
  4. 8.1.3 North America Galidesivir Price by Type (2021-2032)
  5. 8.2 North America Galidesivir Market Size by Application
  6. 8.2.1 North America Galidesivir Revenue by Application (2021-2032)
  7. 8.2.2 North America Galidesivir Sales by Application (2021-2032)
  8. 8.2.3 North America Galidesivir Price by Application (2021-2032)
  9. 8.3 North America Galidesivir Market Size by Country
  10. 8.3.1 North America Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Galidesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Galidesivir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Galidesivir Market Size by Type
  2. 9.1.1 Europe Galidesivir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Galidesivir Sales by Type (2021-2032)
  4. 9.1.3 Europe Galidesivir Price by Type (2021-2032)
  5. 9.2 Europe Galidesivir Market Size by Application
  6. 9.2.1 Europe Galidesivir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Galidesivir Sales by Application (2021-2032)
  8. 9.2.3 Europe Galidesivir Price by Application (2021-2032)
  9. 9.3 Europe Galidesivir Market Size by Country
  10. 9.3.1 Europe Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Galidesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Galidesivir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Galidesivir Market Size by Type
  2. 10.1.1 China Galidesivir Revenue by Type (2021-2032)
  3. 10.1.2 China Galidesivir Sales by Type (2021-2032)
  4. 10.1.3 China Galidesivir Price by Type (2021-2032)
  5. 10.2 China Galidesivir Market Size by Application
  6. 10.2.1 China Galidesivir Revenue by Application (2021-2032)
  7. 10.2.2 China Galidesivir Sales by Application (2021-2032)
  8. 10.2.3 China Galidesivir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Galidesivir Market Size by Type
  2. 11.1.1 Asia Galidesivir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Galidesivir Sales by Type (2021-2032)
  4. 11.1.3 Asia Galidesivir Price by Type (2021-2032)
  5. 11.2 Asia Galidesivir Market Size by Application
  6. 11.2.1 Asia Galidesivir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Galidesivir Sales by Application (2021-2032)
  8. 11.2.3 Asia Galidesivir Price by Application (2021-2032)
  9. 11.3 Asia Galidesivir Market Size by Country
  10. 11.3.1 Asia Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Galidesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Galidesivir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Galidesivir Market Size by Type
  2. 12.1.1 SAMEA Galidesivir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Galidesivir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Galidesivir Price by Type (2021-2032)
  5. 12.2 SAMEA Galidesivir Market Size by Application
  6. 12.2.1 SAMEA Galidesivir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Galidesivir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Galidesivir Price by Application (2021-2032)
  9. 12.3 SAMEA Galidesivir Market Size by Country
  10. 12.3.1 SAMEA Galidesivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Galidesivir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Galidesivir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Galidesivir Value Chain Analysis
  2. 13.1.1 Galidesivir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Galidesivir Production Mode & Process
  6. 13.2 Galidesivir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Galidesivir Distributors
  9. 13.2.3 Galidesivir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst